The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

OBJECTIVE: Prevention of diabetic retinopathy would benefit from availability of drugs that preempt the effects of hyperglycemia on retinal vessels. We aimed to identify candidate drug targets by investigating the molecular effects of drugs that prevent retinal capillary demise in the diabetic rat....

Descripción completa

Detalles Bibliográficos
Autores principales: Gerhardinger, Chiara, Dagher, Zeina, Sebastiani, Paola, Park, Yong Seek, Lorenzi, Mara
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699853/
https://www.ncbi.nlm.nih.gov/pubmed/19401417
http://dx.doi.org/10.2337/db08-1008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699853/
https://www.ncbi.nlm.nih.gov/pubmed/19401417
http://dx.doi.org/10.2337/db08-1008

Ejemplares similares